Target intelligence / Profile preview

Phosphoglycerate mutase 1 pseudogene 2 (PGAM1P2)

Target
PGAM1P2
Molecular classification
Other (Pseudogene), Pseudogene
01

Overview

Phosphoglycerate mutase 1 pseudogene 2 (PGAM1P2) is classified as a pseudogene, meaning it is a non-functional segment of DNA related to the phosphoglycerate mutase 1 gene due to gene duplication or retrotransposition events.[2] Unlike protein-coding genes, pseudogenes generally do not produce a functional protein and therefore are not considered viable therapeutic targets, receptors, enzymes, transporters, or other typical drug targets.[2] Phosphoglycerate mutase 1 (PGAM1) itself is a glycolytic enzyme involved in the interconversion of 3-phosphoglycerate and 2-phosphoglycerate, and may be implicated in cancer and other metabolic diseases[1]. However, PGAM1P2 does not encode a functional enzyme and has no known therapeutic relevance or involvement in pharmacology or disease[2]. PGAM1P2 is listed in genomics resources such as GeneCards and the HUGO Gene Nomenclature Committee (HGNC: 42449), but its annotation indicates it is a pseudogene, not an active gene product[2]. If there are misspellings or confusions regarding PGAM1P2 as a drug target, these should be corrected to refer either to PGAM1 (phosphoglycerate mutase 1), which is an enzyme and a potential drug target, or to clarify that PGAM1P2 is only a pseudogene and not a molecular target[2].

Other names
Phosphoglycerate mutase 1 pseudogene 2PGAM1P2

Beyond the preview

Go deeper on Phosphoglycerate mutase 1 pseudogene 2 (PGAM1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoglycerate mutase 1 pseudogene 2 (PGAM1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call